EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy

Virna Margarita Martín Giménez iD, Javier Modrego, Dulcenombre Gómez-Garre iD, Walter Manucha iD, Natalia de Las Heras iD

International Journal of Molecular Sciences · 31.07.2023 · 24 (15) · 12249

DOI: 10.3390/ijms241512249 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.07.2023. Verfasst von Virna Margarita Martín Giménez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones en Ciencias Químicas, Facultad de Ciencias Químicas y Tecnológicas, Universidad Católica de Cuyo, San Juan 5400, Argenti…. Hauptthemen laut MEDLINE: Dysbiosis, Gastrointestinal Microbiome, COVID-19. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIS, FEDER, FONCyT, Instituto de Salud Carlos III, European Regional Development’s funds (FEDER).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation and oxidative stress are critical underlying mechanisms associated with COVID-19 that contribute to the complications and clinical deterioration of patients. Additionally, COVID-19 has the potential to alter the composition of patients’ gut microbiota, characterized by a decreased abundance of bacteria with probiotic effects. Interestingly, certain strains of these bacteria produce metabolites that can target the S protein of other coronaviruses, thereby preventing their transmission and harmful effects. At the same time, the presence of gut dysbiosis can exacerbate inflammation and oxidative stress, creating a vicious cycle that perpetuates the disease. Furthermore, it is widely recognized that the gut microbiota can metabolize various foods and drugs, producing by-products that may have either beneficial or detrimental effects. In this regard, a decrease in short-chain fatty acid (SCFA), such as acetate, propionate, and butyrate, can influence the overall inflammatory and oxidative state, affecting the prevention, treatment, or worsening of COVID-19. This review aims to explore the current evidence regarding gut dysbiosis in patients with COVID-19, its association with inflammation and oxidative stress, the molecular mechanisms involved, and the potential of gut microbiota modulation in preventing and treating SARS-CoV-2 infection. Given that gut microbiota has demonstrated high adaptability, exploring ways and strategies to maintain good intestinal health, as well as an appropriate diversity and composition of the gut microbiome, becomes crucial in the battle against COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisGastrointestinal MicrobiomeCOVID-19HumansOxidative StressProbioticsSARS-CoV-2InflammationFatty Acids, Volatile

Stichwörter der Autor:innen

COVID-19SARS-CoV-2gut microbiotaimmune systeminflammationprobiotics

Substanzen

Fatty Acids, Volatile

Autor:innen und Institutionen

  • Instituto de Investigaciones en Ciencias Químicas, Facultad de Ciencias Químicas y Tecnológicas, Universidad Católica de Cuyo, San Juan 5400, Argentina.
  • Laboratorio de Riesgo Cardiovascular y Microbiota, Hospital Clínico San Carlos-Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
  • Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Departamento de Fisiología, Facultad de Medicina, Plaza Ramón y Cajal, s/n. Universidad Complutense, 28040 Madrid, Spain.
  • Área de Farmacología, Departamento de Patología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza 5500, Argentina.
  • Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Mendoza 5500, Argentina.

ORCID-Profile: Virna Margarita Martín Giménez, Dulcenombre Gómez-Garre, Walter Manucha, Natalia de Las Heras

Förderung

  • FIS, FEDER, FONCyT
  • Instituto de Salud Carlos III
  • European Regional Development’s funds (FEDER)
  • Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación (FONCyT)

Zitieren

APA

Martín Giménez, V. M., Modrego, J., Gómez-Garre, D., Manucha, W., & de Las Heras, N. (2023). Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy. International Journal of Molecular Sciences, 24(15), 12249. https://doi.org/10.3390/ijms241512249

Vancouver

Martín Giménez VM, Modrego J, Gómez-Garre D, Manucha W, de Las Heras N. Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy. International Journal of Molecular Sciences. 2023;24(15):12249. doi:10.3390/ijms241512249

BibTeX
@article{MartnGimnez2023,
  author = {Martín Giménez, Virna Margarita and Modrego, Javier and Gómez-Garre, Dulcenombre and Manucha, Walter and de Las Heras, Natalia},
  title = {Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {15},
  pages = {12249},
  doi = {10.3390/ijms241512249}
}
Kostenlos starten →